Literature DB >> 7705846

Identification of a PstI polymorphism in the p21Cip1/Waf1 cyclin-dependent kinase inhibitor gene.

J C Law1, A Deka.   

Abstract

A PstI polymorphism in the 3' flanking region of the p21Cip1/Waf1 cyclin-dependent kinase inhibitor gene is described. DNA sequencing analysis identified a C-->T base substitution in the 3' flanking region of the gene. This substitution leads to the destruction of a PstI site and results in a biallelic DNA polymorphism. This restriction fragment length polymorphism (RFLP) provides the first known genetic marker for this cell cycle regulatory gene.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7705846     DOI: 10.1007/bf00208977

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  4 in total

1.  Rapid and reliable fluorescent cycle sequencing of double-stranded templates.

Authors:  W R McCombie; C Heiner; J M Kelley; M G Fitzgerald; J D Gocayne
Journal:  DNA Seq       Date:  1992

2.  WAF1, a potential mediator of p53 tumor suppression.

Authors:  W S el-Deiry; T Tokino; V E Velculescu; D B Levy; R Parsons; J M Trent; D Lin; W E Mercer; K W Kinzler; B Vogelstein
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

3.  p21 is a universal inhibitor of cyclin kinases.

Authors:  Y Xiong; G J Hannon; H Zhang; D Casso; R Kobayashi; D Beach
Journal:  Nature       Date:  1993-12-16       Impact factor: 49.962

4.  The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.

Authors:  J W Harper; G R Adami; N Wei; K Keyomarsi; S J Elledge
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

  4 in total
  1 in total

1.  PCR candidate region mismatch scanning: adaptation to quantitative, high-throughput genotyping.

Authors:  M Beaulieu; G P Larson; L Geller; S D Flanagan; T G Krontiris
Journal:  Nucleic Acids Res       Date:  2001-03-01       Impact factor: 16.971

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.